trial · primary record
Apatinib mesylate
Breast Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT07907354 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:03.374Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07907354
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.